WO2003018629A8 - Cage antigen - Google Patents
Cage antigenInfo
- Publication number
- WO2003018629A8 WO2003018629A8 PCT/KR2002/001576 KR0201576W WO03018629A8 WO 2003018629 A8 WO2003018629 A8 WO 2003018629A8 KR 0201576 W KR0201576 W KR 0201576W WO 03018629 A8 WO03018629 A8 WO 03018629A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cage
- antigen
- various
- dna
- codes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20010050836 | 2001-08-23 | ||
KR2001/50836 | 2001-08-23 | ||
US10/195,117 US20030092083A1 (en) | 2001-08-23 | 2002-07-11 | Cage antigen |
US10/195,117 | 2002-07-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003018629A1 WO2003018629A1 (en) | 2003-03-06 |
WO2003018629A8 true WO2003018629A8 (en) | 2004-05-27 |
Family
ID=26639314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2002/001576 WO2003018629A1 (en) | 2001-08-23 | 2002-08-20 | Cage antigen |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2003018629A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100478509C (en) | 2001-12-05 | 2009-04-15 | 休闲生活世界股份有限公司 | Method for making furniture by using synthesized weaving material |
FR2854903A1 (en) * | 2003-05-13 | 2004-11-19 | Centre Nat Rech Scient | In vitro diagnosis of cancer, based on detecting hypomethylation of deoxycytidine in CpG doublets present in specific sequences from the B melanoma antigen locus |
WO2008091873A2 (en) | 2007-01-24 | 2008-07-31 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for the identification, assessment, prevention and therapy of thymic lymphoma or hamartomatous tumours |
JP5267969B2 (en) * | 2007-12-04 | 2013-08-21 | 学校法人慶應義塾 | Cancer vaccine |
KR102073144B1 (en) * | 2018-12-13 | 2020-02-04 | 주식회사 엘베이스 | Pharmaceutical Composition for Preventing or Treating Cancer Comprising Oligopeptide |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245525B1 (en) * | 1998-07-27 | 2001-06-12 | Ludwig Institute For Cancer Research | Tumor associated nucleic acids and uses therefor |
-
2002
- 2002-08-20 WO PCT/KR2002/001576 patent/WO2003018629A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003018629A1 (en) | 2003-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002092818A8 (en) | Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets | |
WO2002095051A3 (en) | Mage-a3 peptides presented by hla class ii molecules | |
WO2003014303A3 (en) | Molecular interactions in cells | |
WO2006028429A3 (en) | Peptides for targeting the prostate specific membrane antigen | |
WO1998059040A3 (en) | Human catalytic telomerase sub-unit and its diagnostic and therapeutic use | |
WO2005026205A3 (en) | Genetic products which are differentially expressed in tumours and use thereof | |
WO2001046225A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2003018629A8 (en) | Cage antigen | |
WO2004092212A3 (en) | Tumor antigens bfa5 for prevention and/or treatment of cancer | |
WO2005033265A3 (en) | Optimized multi-epitope constructs and uses thereof | |
WO2005013904A3 (en) | Sars nucleic acids, proteins, vaccines, and uses thereof | |
WO2001059120A3 (en) | Il-17 like molecules and uses thereof | |
PL374550A1 (en) | Il-17 like molecules and uses thereof | |
WO2001027254A3 (en) | Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy | |
WO2005049793A3 (en) | Methods and compositions for combinatorial approaches to cancer gene therapy | |
WO2005023979A3 (en) | Isolated s. mansoni nucleic acid molecules and uses thereof | |
WO2001031343A3 (en) | Diagnosis and therapy of cancer using sgp28-related molecules | |
AU2001292326A1 (en) | Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like | |
WO2002044366A3 (en) | Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 | |
WO2004053117A3 (en) | Serine protease | |
WO2004076613A3 (en) | Human nucleic acid sequences from carcinomas of the bladder | |
AU2002326318A1 (en) | Targeting tumor cell antigens: antibodies useful for the diagnosis, prognosis, and treatment of cancer | |
WO2002063013A3 (en) | Human acid phosphatase gene | |
EP1383871A4 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
AU2001227570A1 (en) | Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VC VN YU ZA ZM Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 10/2003 UNDER (72) ADD "JEOUNG, DOOIL; 7-1308 MISUNG APT., BULGWANG-DONG, EUNPYUNG-GU, 122-040 SEOUL (KR). CHO, BOMSOO; 604 HYUNDAI AHYUN APT., AHYUN 1-DONG, MAPO-GU, 121-011 SEOUL (KR). LIM, YOON; 95-58 SONGPA 1-DONG, SONGPA-GU, 138-850 SEOUL (KR). PARK, SAEYOUNG; 101 LOTTEGREEN MANSION, 69-43 DOWON-DONG, JUNG-GU, 400-140 INCHON (KR). LEE, DAEYEON; 7-708 DONGBU APT., 66-26 SONGHYUN 1-DONG, DONG-GU, 401-761 INCHON (KR). BANG, YUNGJUE; 120-604 HUYNDAI APT., 434 APGUJEONG-DONG, KANGNAM-GU, 135-110 SEOUL (KR). YANG, HANKWANG; 14-601 SAMHO APT., BANGBAE-DONG, SEOCHO-GU, 137-759 SEOUL (KR)." |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |